Comments

TuHURA Biosciences (HURA) Stock Price, Quote, News & History

Q: What sector and industry does TuHURA Biosciences (HURA) operate in?

TuHURA Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

HURANASDAQ

Logo brought to you by Benzinga Data

Trade with Public

$2.05

0.010.49%

At close: Nov 14, 4:00 PM EST

$2.05

N/A

After Hours: Nov 14, 4:00 PM EST

Q3 2025 Earnings were released on Fri Nov 14th, before the market open

Overview

News Earnings Analyst Ratings Short Interest Government Trades Stock Report

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$2.03

$2.05

Volume / Avg.

162.59K / 239.58K

Day Range

$2.03 - $2.18

52 Wk Range

1.80 - 7.20

Market Cap

$104.76M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

5.3%

Days to Cover

11.52

Recent TuHURA Biosciences Inc News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Key Statistics

Open

$2.03

$2.05

Volume / Avg.

162.59K / 239.58K

Day Range

$2.03 - $2.18

52 Wk Range

1.80 - 7.20

Market Cap

$104.76M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

5.3%

Days to Cover

11.52

About

Sector

Health Care

Industry

Biotechnology

TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry